What are the guidelines for colorectal cancer (CRC) screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Colorectal cancer screening should begin at age 50 for average-risk individuals and continue until age 75, with the preferred screening options including colonoscopy every 10 years, fecal immunochemical test (FIT) annually, or stool DNA testing every 3 years, as recommended by the American College of Physicians 1. The Malaysian Colorectal Cancer CPG guidelines are not directly provided, but based on the available evidence from the American College of Physicians, the recommended screening options and intervals are as follows:

  • Fecal immunochemical testing or high-sensitivity guaiac-based fecal occult blood testing every 2 years
  • Colonoscopy every 10 years
  • Flexible sigmoidoscopy every 10 years plus fecal immunochemical testing every 2 years High-risk individuals, such as those with a family history of colorectal cancer, personal history of inflammatory bowel disease, or certain genetic syndromes, should begin screening earlier and undergo more frequent surveillance, as recommended by the American Cancer Society 1. Some key points to consider when discussing screening options with patients include:
  • The benefits and harms of each screening test, including the potential for false-positive and false-negative results
  • The importance of adherence to the recommended screening interval and the potential consequences of non-adherence
  • The role of patient preferences and values in the decision-making process
  • The need for personalized decisions for those aged 76-85 based on health status and prior screening history It is essential to note that the evidence suggests that no test has demonstrated a reduction in all-cause mortality, but some tests have shown a reduction in CRC-specific mortality, as reported in the study by the American College of Physicians 1.

From the Research

Colorectal Cancer Screening Guidelines

The Malaysian Colorectal Cancer CPG recommends the following for colorectal cancer screening:

  • Screening should begin at age 45 for average-risk individuals 2
  • For high-risk individuals with a positive family history of colorectal cancer or advanced colorectal polyp, screening should begin at age 40 3, 4
  • Recommended screening modalities include:
    • Colonoscopy every 10 years for average-risk individuals and every 5-10 years for high-risk individuals 3, 4
    • Fecal Immunochemical Test (FIT) annually for average-risk individuals and every 1-2 years for high-risk individuals 3, 4
    • Computed Tomographic Colonography (CTC) every five years for all individuals 3

Screening Strategies

Different screening strategies have been evaluated, including:

  • Fecal occult blood testing with colonoscopy follow-up of all positive tests 5, 6
  • Flexible sigmoidoscopy with colonoscopy follow-up of all adenomatous polyps 5, 6
  • Flexible sigmoidoscopy with colonoscopy follow-up of all adenomatous polyps > 10 mm in size 6

Implementation of Screening Programs

The implementation of colorectal cancer screening programs in Malaysia has been tailored to meet the needs of the population based on available existing resources 2. A well-mapped budget for the entire screening program continuum, a strong partnership between stakeholders, and an opportunistic screening strategy are crucial to address the rising incidence of colorectal cancer 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.